Renalytix Plc Stock Deutsche Boerse AG

2O9

GB00BYWL4Y04

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG 17:25:01 02/10/2026 +04			5-day change	1st Jan Change
0.0680 ^EUR	+1.49%		-1.45%	+8.80%

09-30	Renalytix Plc - Shareholder/Analyst Call
09-28	Renalytix Nonexecutive Chair to Resign at End of 2026	MT

Last Transcript: Renalytix Plc

Renalytix Plc - Shareholder/Analyst Call

09-30

More transcripts

Analysts' recommendations: Renalytix Plc

03/04/23	BTIG Adjusts Price Target on Renalytix to $3.50 From $4, Maintains Buy Rating	MT
03/04/23	HC Wainwright Adjusts Price Target on Renalytix to $5 From $8, Maintains Buy Rating	MT
01/11/22	HC Wainwright Adjusts Renalytix's Price Target to $10 From $15, Keeps Buy Rating	MT
01/07/22	BTIG Adjusts Renalytix's Price Target to $5 From $15, Maintains Buy Rating	MT
01/07/22	Stifel Adjusts Renalytix's Price Target to $7 from $17, Keeps Buy Rating	MT

More recommendations

News in other languages: Renalytix Plc

01/07/23	Aktien New York Schluss: Nasdaq 100 mit Rekordplus im ersten Halbjahr
30/06/23	Aktien New York: Deutliche Gewinne untermauern gute Wochen- und Halbjahresbilanz
30/06/23	Aktien New York Ausblick: Positiver Wochen- und Halbjahresabschluss in Aussicht
30/06/23	USA-Les valeurs à suivre à Wall Street (actualisé)
30/06/22	Point sur les fortes variations du jour : Metabolic Explorer se fait étrillé

More news

Managers and Directors: Renalytix Plc

Manager	Title	Age	Since
James McCullough CEO	Chief Executive Officer	58	15/03/2018
Joel Jung DFI	Director of Finance/CFO	68	28/05/2024
Howard Doran PSD	President	65	30/04/2024

Director	Title	Age	Since
Julian Baines CHM	Chairman	62	05/11/2024
James McCullough BRD	Director/Board Member	58	15/03/2018
Christopher Mills CHM	Chairman	74	-

More insiders

Medical Diagnostic & Testing Equipment

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RENALYTIX PLC	+1.49%	-1.45%	-	-	47.93M
THERMO FISHER SCIENTIFIC, INC.	+0.35%	-2.99%	+20.52%	+30.32%	242B
DANAHER CORPORATION	+1.09%	-4.65%	-0.43%	-0.93%	150B
INTUITIVE SURGICAL, INC.	-2.32%	-3.27%	-13.35%	+35.02%	138B
BOSTON SCIENTIFIC CORPORATION	-1.46%	-3.01%	-56.23%	-17.36%	61.74B
EDWARDS LIFESCIENCES CORPORATION	-0.05%	-1.32%	+10.48%	+19.48%	49.08B
SIEMENS HEALTHINEERS AG	+0.66%	+0.19%	-20.53%	-21.81%	47.43B
AGILENT TECHNOLOGIES, INC.	+0.66%	-2.90%	+18.46%	+50.25%	47.3B
VEEVA SYSTEMS INC.	-3.05%	-2.62%	-7.75%	+36.34%	44.25B
WATERS CORPORATION	-0.08%	-1.92%	+29.48%	+58.80%	41.78B
Average	-0.27%	-2.50%	-2.15%	+21.12%	91.4B
Weighted average by Cap.	-0.29%	-2.98%	+1.08%	+21.08%

See all sector performances

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
02/10/26	€0.0680	+1.49%
01/10/26	€0.0670	-4.96%
30/09/26	€0.0705	+5.22%
29/09/26	€0.0670	-2.19%
28/09/26	€0.0685	-0.72%

Delayed Quote Deutsche Boerse AG

More quotes

Annual profits - Rate of surprise

Company calendar

Market Cap	13.34M 11.85M 11.06M 10.08M 19.01M 1.28B 19.19M 134M 51.86M 655M 50.07M 48.98M 2.1B	P/E 2024	-0.45x	P/E 2025	-1.34x
Enterprise Value	17.94M 15.94M 14.87M 13.56M 25.57M 1.72B 25.81M 180M 69.75M 881M 67.34M 65.88M 2.83B	EV / Sales 2024	11,059,330x	EV / Sales 2025	12,499,418x
Free-Float	81.69%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
London S.E.	RENX	Delayed
OTC Markets	RENX.F	Delayed
Deutsche Boerse AG	2O9	Delayed
Börse Stuttgart	2O9	Delayed
Boerse Muenchen	2O9	Real-time

09-30	Renalytix Plc - Shareholder/Analyst Call
09-28	Renalytix Nonexecutive Chair to Resign at End of 2026	MT
09-28	Julian Baines to Stand Down as Non-Executive Chair of Renalytix Plc on Effective December 31, 2026	CI
09-14	Renalytix plc Changes Its Financial Year-End from June 30 to December 31	CI
09-09	EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows	AN
09-08	FTSE 100 slips as Bailey flags inflation risks	AN
09-08	WINNERS & LOSERS: STV hurt by Studios "slowdown"; Trifast falls	AN
09-08	Renalytix Raises Funds via Retail Offer	MT
09-03	Futura Medical's fundraise and formal sale process	AN
09-03	Renalytix Raises GBP10 Million via Share Placing, Subscription	MT
09-01	Shaires completes Anthropic and Stripe investments	AN
09-01	Renalytix Plans GBP9.5 Million Share Placing, Subscription	MT
07-06	WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million	AN

04-14	Renalytix : Fincial document - (RENX Half Year Report 26.03.26)	PU
11-18	Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes	PR
15/09/25	Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease	PR
21/12/24	Renalytix : Result of AGM Form 8 K	PU
26/11/24	Renalytix : Proxy Card 2024 (for holders of ADSs)	PU

1 day	+1.49%
1 week	-1.45%
Current month	-3.55%
1 month	+72.15%
3 months	+189.36%
6 months	+202.22%
Current year	+8.80%

Renalytix Plc Stock Deutsche Boerse AG

Stocks

2O9

GB00BYWL4Y04

Advanced Medical Equipment & Technology

Valuation: Renalytix Plc

Chart: Renalytix Plc

Latest news: Renalytix Plc

Last Transcript: Renalytix Plc

Analysts' recommendations: Renalytix Plc

Press Releases: Renalytix Plc

News in other languages: Renalytix Plc

Quotes and Performance

Price Extremes

Managers and Directors: Renalytix Plc

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 week	0.07	0.07
1 month	0.06	0.07
Current year	0.01	0.07
1 year	0.01	0.1
3 years	0.01	0.62
5 years	0.01	11.3
10 years	0.01	13.6

	2024	2025
Net sales	2.29 2.03 1.9 1.73 3.26 220.05 3.29 22.97 8.9 112.49 8.59 8.41 361.03	3 2.67 2.49 2.27 4.28 288.4 4.32 30.11 11.67 147.43 11.26 11.02 473.17
Net income	-33.46M -29.73M -27.74M -25.29M -47.69M -3.22B -48.14M -336M -130M -1.64B -126M -123M -5.28B	-20.4M -18.13M -16.92M -15.42M -29.08M -1.96B -29.35M -205M -79.33M -1B -76.59M -74.93M -3.22B
Net Debt	3.86M 3.43M 3.2M 2.91M 5.5M 371M 5.55M 38.69M 14.99M 189M 14.47M 14.16M 608M	4.6M 4.09M 3.81M 3.48M 6.56M 442M 6.62M 46.16M 17.89M 226M 17.27M 16.9M 726M